6505--PLUVICTOâ„¢ (lutetium Lu 177 vipivotide tetraxetan) Prostate Cancer Therapy (NDC Code: 69488-0010-61) VA Palo Alto Health care System
SAM.GOV Due: June 10, 2025 at 10:00 PM UTC
In-Active Special Notice Source Url

Summary

The opportunity involves the provision of PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan) for prostate cancer therapy at the VA Palo Alto Health Care System. This special notice is aimed at contractors who can supply this specific cancer treatment, which is identified by the NDC Code: 69488-0010-61. Businesses with experience in pharmaceutical supply, particularly those specializing in oncology products, are encouraged to bid on this opportunity. The contract is expected to support the healthcare needs of veterans, emphasizing the importance of quality and timely delivery of medical supplies.
Entities
VADO
Department of Veterans Affairs
NAICS
325412
Set Aside
None
Place of Performance
Point of Contact
Full Name Email Phone Type
Mohammed Hussain [email protected] 916-923-4534 primary
Attachments
  • 36C26126Q0002.docx